Skip to main content

Table 5 Effect of ANC characteristics of respondent on IPTp-SP uptake of ≥3 doses

From: Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana

Characteristics IPTp-SP uptake COR (95% CI) p value AOR (95% CI) p value
<3 doses n (%) ≥3 doses n (%)
Gestational age at first ANC visit
 First trimester 7 (6.67) 98 (93.33) Ref   Ref  
 Second trimester 12 (9.52) 114 (90.48) 0.68 (0.26–1.79) 0.434 0.74 (0.22–2.46) 0.630
 Third trimester 13 (54.17) 11 (45.83) 0.06 (0.02–0.18) <0.001 2.8 (0.31–24.55) 0.352
Number of visits
 <4 14 (48.28) 15 (51.72) Ref   Ref  
 ≥4 18 (7.96) 208 (92.04) 10.76 (4.5–25.82) <0.001 4.57 (1.15–18.16) 0.031
Gestational age at first dose of SP
 Second trimester 11 (5.05) 207 (94.95) Ref   Ref  
 Third trimester 18 (52.94 16 (47.06) 0.05 (0.02–0.12) <0.001 0.04 (0.01–0.16) <0.001
  1. COR crude odds ratio, AOR adjusted odds ratio, 95% CI 95% confidence interval, Ref reference
  2. Significant p values are presented in italics